Skip to content
Review Open access

Utility of repeat stereotactic EEG in pediatric patients with tuberous sclerosis

Jul 2026 · Epilepsia Open · 0 citations · 47 references
Medicine

TL;DR

It is suggested that repeat sEEGs may help guide effective treatment in children with multifocal epilepsy, while multifocal networks may necessitate additional sEEG evaluations and subsequent surgeries, favorable seizure outcomes can be achieved.

Abstract

Abstract Objective Tuberous sclerosis complex (TSC) is a rare genetic disorder associated with early‐onset drug‐resistant epilepsy (DRE) secondary to intracranial tubers. Many patients undergo stereo‐EEG (sEEG) for seizure onset localization, sometimes requiring multiple sEEGs and subsequent epilepsy surgeries. Our objective was to evaluate the effects of single versus multiple sEEGs on seizure outcomes in pediatric patients with TSC‐associated DRE. Methods Retrospective review of 45 pediatric TSC patients who underwent epilepsy surgery at our institution (2/2013–4/2026). Collected data included demographics, seizure history, number of sEEGs, surgical interventions, and outcomes. Primary outcomes were Engel scores after definitive epilepsy surgery. Results Among 34 identified TSC patients who underwent sEEG prior to surgery, 19 had one sEEG, 15 had two or more (mean ± SE: 2.4 ± 0.2, range: 2–5). 68% of single sEEG patients had one presumed seizure focus on phase I vEEG versus only 27% of multiple sEEG patients (p = 0.03). Phase I vEEG and MEG data were concordant in 67% of single sEEG patients and 91% of multiple sEEG patients. Single ictal focus epilepsy on vEEG was significantly associated with use of only single sEEG on logistic regression (p = 0.01). Patients with a single sEEG more often underwent laser ablation (53% vs. 27%), while those with multiple sEEGs more commonly underwent resective surgery (73% vs. 47%, p = 0.171). Four patients (20%) in the single sEEG group had additional treatment surgeries without repeat sEEG. At one‐year and most recent (2.3 ± 0.4 vs. 2.8 ± 0.4 years) follow‐up in patients who had at least 1 year of follow up after their most recent surgery (n = 24, 82%), favorable seizure outcomes (Engel I/II) were observed in 86% and 93% in single sEEG patients, and 64% and 79% in multiple sEEG patients (p > 0.99). Significance TSC‐associated DRE is often multifocal and challenging to treat, requiring sEEG for localization. Presurgical multifocal vEEG or MEG findings may predict need for repeat sEEG. While multifocal networks may necessitate additional sEEG evaluations and subsequent surgeries, favorable seizure outcomes can be achieved. Plain Language Summary Tuberous sclerosis complex (TSC) is a rare genetic condition that often causes difficult‐to‐control epilepsy in children. Some patients need a procedure called stereo‐EEG (sEEG) to locate where seizures begin in the brain before surgery. We reviewed 34 children with TSC who underwent sEEG before epilepsy surgery. Children with a single seizure focus were more likely to need only one sEEG, while those with multiple seizure areas often required repeat sEEGs and additional surgeries. Despite more complex epilepsy, many patients still achieved good seizure control after treatment. These findings suggest that repeat sEEGs may help guide effective treatment in children with multifocal epilepsy.

Read PDF

Similar papers

Review Aug 2026

Epilepsy outcomes following single and repeat epilepsy surgeries in tuberous sclerosis complex.

OBJECTIVE Epilepsy surgery in tuberous sclerosis complex (TSC) is underutilized but associated with improved seizure control and better neurocognitive outcomes. Here we focus on utilization of repeated surgeries to improve seizure control. METHODS We performed a retrospective chart review of 62 pediatric patients wit...

Alexandria Valdrighi, Kevin Pearsson, Jurriaan M. Peters et al. · 0 citations
Jul 2026

Epilepsy and disability in adults with tuberous sclerosis complex: a 16-year retrospective analysis

Childhood drug-resistant epilepsy was the strongest predictor of persistent adult seizures and disability and TSC2 mutations were linked to a more severe phenotype but does not predict the course of epilepsy in adulthood, supporting early, optimized seizure management.

Q. Calonge, A. Hanin, Maëlle Dade et al. · 0 citations
Review Jul 2026

Thalamic neuromodulation for pediatric drug-resistant epilepsy: a case series evaluating deep brain stimulation and responsive neurostimulation.

Thalamic neuromodulation using DBS and RNS was safe and well tolerated in pediatric patients with DRE, including multifocal and generalized seizure onsets, with a trend toward greater benefit in the DBS group.

Dominic Nistal, Benjamin D. Edmonds, Adriel Barrios-Anderson et al. · 0 citations
Review Open access Sep 2026

Pediatric occipital lobe epilepsy: A modern review of etiological classification, management, and outcomes

This review examines the evolving landscape of pediatric OLE, highlighting the shift from syndromic to etiological classification and management strategies and the need to monitor cognitive comorbidities and syndrome evolution.

Preeti Srivastava, D. Nag, Shikha Swaroop et al. · 0 citations
Review Open access Aug 2026

Awake craniotomy for drug-resistant non-oncological epilepsy: a systematic review of feasibility, reported safety, and seizure outcomes

In carefully selected patients with drug-resistant non-tumor epilepsy involving or adjacent to eloquent cortex, AC with intraoperative functional mapping appears feasible and may help preserve neurological function while enabling tailored resection.

M. Mofatteh, M. Mashayekhi, Sho Giersztein et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.